Results 21 to 30 of about 25,697 (255)
Conotoxin Patenting Trends in Academia and Industry
Marine Drugs, 2022 Sea snails of the genus Conus produce toxins that have been the subjects of numerous studies, projects, publications, and patents over the years. Since Conus toxins were discovered in the 1960s, their biological activity has been thought to have high ...
Noemi Sanchez-Campos +2 more
doaj +1 more source
Effective patent life in pharmaceuticals [PDF]
International Journal of Technology Management, 2000 Effective patent life is lost in pharmaceuticals because of the lengthy time periods required for clinical trials and regulatory approval. A 1984 US law restores some of this lost patent time, while also facilitating generic competition when patents expire.
Grabowski, Henry, John Vernon
openaire +1 more source
Patents associated with high-cost drugs in Australia. [PDF]
PLoS ONE, 2013 Australia, like most countries, faces high and rapidly-rising drug costs. There are longstanding concerns about pharmaceutical companies inappropriately extending their monopoly position by "evergreening" blockbuster drugs, through misuse of the patent ...
Andrew F Christie +4 more
doaj +1 more source
AI-driven molecular generation of not-patented pharmaceutical compounds using world open patent data
Journal of Cheminformatics, 2023 Developing compounds with novel structures is important for the production of new drugs. From an intellectual perspective, confirming the patent status of newly developed compounds is essential, particularly for pharmaceutical companies.
Yugo Shimizu +6 more
doaj +1 more source
Globalization and Health, 2018 Background Despite the significant impact of pharmaceutical innovations on healthcare, our understanding is still limited because previous studies explored only a few cases and largely came from a linear perspective.
Qiaolei Jiang, Chunjuan Luan
doaj +1 more source
Pharmaceutics, 2021 We present a data-driven approach to unveil the pharmaceutical technologies of cyclodextrins (CDs) by analyzing a dataset of CD pharmaceutical patents.
Juliana Rincón-López +3 more
doaj +1 more source
Pravo, 2021 In recent years, public health systems in high-income countries have been heavily exposed to pressures due to high drug prices. High drug prices are affected by market monopolies that pharmaceutical companies have thanks to patents, i.e.
Sonja Lučić
doaj +1 more source
The Journal of Qazvin University of Medical Sciences, 2020 Today, along with the relative expansion of public health around the world, various diseases such as AIDS, malaria, etc. are increasing in human societies. In this regard, the pharmaceutical industry is one of the most important industries that should be
Somayeh Rahmani +2 more
doaj +1 more source
Pharmaceutical Innovations: Superior Position of the USA and Weaknesses of German Research
Wirtschaftsdienst, 2021 The innovative strength of research performance is often measured in terms of inputs such as research funds or outputs such as patent applications. We present a novel indicator of pharmaceutical innovativeness that focuses on global medical breakthroughs
Andreas Eckert, Wolfgang Maennig
doaj +1 more source
The Gaming of Pharmaceutical Patents [PDF]
Innovation Policy and the Economy, 2004 Paragraph IV of the Hatch-Waxman Act provides a mechanism for the litigation of pharmaceutical patent infringement disputes. Many of these cases have been settled with "reverse payments" by the brand to the generic in return for delayed generic entry. The FTC has contested a number of these settlements with good but not complete success.
+4 more sources